It is used to control, prevent and normalize the symptoms associated with Alzheimer's disease, attention disorder, bipolar disorder, Parkinson's disease among others
Adds to Merck’s growing global, multi-modality CDMO network, following newly formed CDMO business unit in Life Science
The researchers are of the view that the new drug designing strategy demonstrated by them could also be adopted to treat retroviral infections.
Since the beginning of the pandemic, more than one million patients with severe COVID-19 have been treated with Actemra/RoActemra
The company will now be allowed to sell its proprietary and validated tinctures, gummies, and capsules across the UK
The focus should be on streamlining regulations, developing new molecules, increased industry academia collaboration and tapping the potential of traditional medicines
More than 2,500 submissions are currently under review in the Food and Drug Administration's (FDA) cell and gene therapy pipeline
Last year, the company's early-stage breast cancer detection test became the first such test to receive the Breakthrough Device Designation
Launches a host of innovative products & solutions across the entire flexible packaging value chain in October - December 2021
The three prequalified products are manufactured by the originator company, Roche, but the listings should pave the way for more companies coming forward to seek WHO prequalification
Subscribe To Our Newsletter & Stay Updated
